Among death ligands, TRAIL has been proved to be a safe and effective biological agent for cancer therapy because TRAIL-based therapy offers a profound apoptotic effect but without causing obvious adverse effects on normal cells [5, 22]. This evidence concerns the gene TNFSF10 and cancer.